deflazacort (emflaza) Report issue

Small molecule Orphan Drug FDA Approved FDA First in Class Fast Track FDA Priority Review FDA

Active Ingredient History

  • Now
Deflazacort is a glucocorticoid developed for the treatment of different inflammatory and immune conditions. The drug is rapidly metabolized to an active metabolite, 21-hydroxy-deflazaxort that may cross the blood brain barrier. Deflazacort acts by suppressing inflammatory response.   NCATS

  • SMILES: CC1=N[C@@]2([C@@H](C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]23C)O1)C(=O)CO
  • Mol. Mass: 399.4801
  • ALogP: 2.56
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Oral
  • Pro Drug: Yes

Drug Pricing (per unit)

United States

$33.2574 - $185.3143
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

(11 beta,16 beta)-21-(acetyloxy)-11-hydroxy-2'- methyl-5'h-pregna-1,4-dieno(17,16-d)oxazole-3,20- dione | azacort | azacortinol | calcort | deflazacort | dezacor | dezacort | emflaza | flantadin | lantadin | mdl-458 | oxazacort | zamene


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue